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In order to study the eﬃcacy of linear-polarized near-infrared light irradiation (LPNIR) on relieving chronic pain in conjunction
with nerve block (NB) or local block (LB), a 3-week prospective, randomized, double-blind, controlled study was conducted to
evaluate the pre- and post-therapy pain intensity. Visual analogue scales (VASs) were measured in all patients before and 6 months
after therapy visiting the pain clinic during the period of August 2007 to January 2008. A total of 52 patients with either shoulder
periarthritisormyofascialpainsyndromeorlateralepicondylitiswererandomlyassignedintotwogroupsbydrawinglots.Patients
in Group I were treated with NB or LB plus LPNIR; Group II patients, for their part, were treated with the same procedures as in
Group I, but not using LPNIR. In both groups, the pain intensity (VAS score) decreased signiﬁcantly immediately after therapy as
compared to therapy. There was a signiﬁcant diﬀerence between the test and control groups immediately after therapy (P<0.05),
while no eﬀect 6 months later. No side eﬀects were observed. It is concluded that LPNIR is an eﬀective and safe modality to treat
various chronic pains, which has synergic eﬀects with NB or LB.
1.Introduction
Nerve block (NB) or local block (LB) has conventionally
been the main stream in treating chronic pain due to its
reliable eﬀects and convenience to apply. Repeated injections
of the anesthetics and steroids at the same points, however,
may cause local muscle damage and scarring. In addition,
in many cases one-time injection may not provide a lasting
eﬀect to relieve chronic pain. Therefore, it is expected
to develop a method to enhance the eﬀects of NB or
LB to obtain a better outcome, while reducing the times
of injection. Recently, a noninvasive method, the linear-
polarized near-infrared light irradiation (LPNIR), has been
used eﬀectively to relieve chronic pain from frozen shoulder,
osteoarthritis, rheumatoid arthritis, postherpetic neuralgia,
and other disorders [1–3]. We hypothesized that LPNIR
in conjunction with NB or LB might provide better pain
relief than NB or LB alone. Therefore, in the current
study we evaluated the eﬀect of LPNIR in conjunction
with NB/LB in relieving chronic pain in the patients with
shoulder periarthritis, back myofascial pain syndrome, or
lateral epicondylitis.
2.MaterialsandMethods
A prospective, randomized, double-blinded study was con-
ducted in our pain clinic from August 2007 to January 2008.
Patients with chronic pain due to shoulder periarthritis,
back myofascial pain syndrome, or lateral epicondylitis were
randomly classiﬁed into two groups by drawing lots. Group I
were treated with NB or LB plus LPNIR; Group II treated
with the same procedures as in Group I, but without
switching the machine on. A curtain was placed between
the patient and the LPNIR machine, which is quite quiet
when it is working. Therefore, both the patients and the2 The Scientiﬁc World Journal
administrator of the treatment did not know which arm
the patient was in. The study protocol was approved by
the Ethics Committee of the Third Hospital of XiangYa
SchoolofMedicine.Aninformedconsentformwasobtained
from each patient after the subject was informed about the
purpose of the study, the protocol, possible side eﬀects of the
administered agents, and risks and beneﬁts of participation
in the study.
Each potentially eligible subject who visited the pain
clinic during the trial period was examined by the physician
responsible for the trial to determine the suitability for
inclusion in the study. Inclusion criteria were age > 18 years,
chronic pain persisted for >3 months due to shoulder peri-
arthritis, myofascial pain syndrome, or lateral epicondylitis,
and with VAS scores > 5 (rating scale from 0 to 10). Patients
with VAS scores < 5, or with existing contraindications for
NB or LB, or simultaneously treated with other analgesic
drugs or methods were excluded from participation in the
study. Data from the patients that failed to follow up after
the initiation of treatment from both of the study arms were
analyzed using the last value before losing followup.
The following are the diagnostic criteria for the three
diseases investigated in the current study:
Shoulder Periarthritis:
(1) Patients around their ﬁfties, more likely to be female
than male, mostly physical laborers;
(2) Pain around shoulders, especially at night and often
chronic onset, always induced by weather changes
and fatigue;
(3) Movement of glenohumeral joint is limited by pain,
which may gradually become less painful but more
restricted in motion;
(4) Atrophy of the shoulder muscle, tenderness in ante-
rior, posterior and lateral aspects of the shoulder,
markedlimitationofshoulderabductionwithtypical
shoulder carrying;
(5) X-ray examination usually shows negative outcome,
but osteoporosis may occur with chronic duration.
Back Myofascial Pain Syndrome:
(1) Muscle pain with speciﬁc “trigger” or “tender” points
which can be made worse with activity or stress.
Trigger points can be identiﬁed by pressure to an area
of a person’s body;
(2) Potential subjects can suﬀer from depression, fatigue,
and behavioral disturbances.
Lateral Epicondylitis:
(1) Pain that radiates from the outside of the elbow into
the forearm and wrist;
(2) Pain when touching or bumping the outside of the
elbow;
Table 1: Demographics of enrolled subjects in the two groups.
Group I
(block + LPNIR)
Group II
(block only)
Gender:
Male 7 (26.9%) 9 (34.6%)
Female 19 (73.1%) 17 (65.4%)
Age (mean ± SD) 53.69 ±13.01 45.73 ±13.49
Type of chronic pain:
Shoulder periarthritis 10 (38.5%) 8 (30.8%)
Myofascial pain syndrome 13 (50.0%) 12 (46.2%)
Lateral epicondylitis 3 (11.5%) 6 (23.1%)
Total cases 26 26
SD: standard deviation.
(3) A weak grip;
(4) X-ray ﬁnding is negative.
3.StatisticalAnalysis
The diﬀerences between the two groups before therapy, and
those within the same group obtained pre- and post-therapy,
as well as the means of the diﬀerences pre- and post-therapy
between the two groups—means of the treatment eﬀects
in the two groups were compared by unpaired or paired
t-test using the program MedCalc version 11 (MedCalc
Software Ltd., Mariakerke, Belgium) when it is applicable.
The changes were estimated to be normally distributed. The
eﬀect of gender and age was also evaluated with the same
method. A P value of <0.05 was considered signiﬁcant.
4. Results
52 patients suﬀering from shoulder periarthritis, back
myofascial pain syndrome, or lateral epicondylitis were
enrolled in this study. Among them, there were 36 females
and 16 males, age from 19 to 79 years old. By drawing
lots, they were assigned randomly into two groups. The
demographic data of the two groups were shown in Table 1.
In Group I, subjects received LPNIR near pain points
3t i m e saw e e ka sw e l la sN Bo rL Bo n c eaw e e k .T h e
mixture of lidocaine (1%), bupivacaine (0.375%), and
methylprednisolone acetate (0.25%) was used in LB or NB.
Inthecasesoflateralepicondylitisandshoulderperiarthritis,
4mL and 6mL of the mixture were injected into the pain
points or “trigger” points, respectively, whereas in the back
myofascial pain syndrome, the intercostal nerve involved was
targeted with 8mL of the mixture.
The LPNIR with a wavelength of 830nm produced by
LX-PZ99 (Zhuhai Concon Medical Instrument Co. Ltd.,
China) was set to the therapy model that irradiation circle
was2:3(irradiation2secondsfollowedby3-secondspause).
Each pain point was irradiated 10min at 80% power output
and treated for 3 weeks. The maximum power output is
1800mW at a wavelength of 600 to 1600nm.The Scientiﬁc World Journal 3
Table 2: The VAS scores pre- and immediately post-therapy in two
groups.
Pretherapy
(mean ± SE)
Posttherapy
(mean ± SE)
Group I 7.77 ±0.28 1.54 ±0.31#
Group II 8.00 ±0.28† 3.08 ±0.41#
†P>0.05 as compared with Group I; #P<0.005 as compared with
pretherapy.
SE: standard error.
Table 3: Means of diﬀerences between pre- and immediately post-
therapy.
Group Diﬀerences (treatment eﬀects)
(mean ± SE)
I6 .23 ±0.45
II 4.92 ±0.42∗
∗P<0.05 as compared with Group I; SE: standard error.
In Group II (the control group), the medicines and the
therapeutic procedures were the same as in Group I, just
without switching on the LPNIR.
The pain relief eﬀects were evaluated by comparing the
visualanaloguescales(VAS)scorespriorto,immediatelyand
6 months after the treatment. VAS scores were graded as 0
with no pain and 10 as most pain imaginable.
The demographic data for the 52 subjects enrolled in the
study were described in Table 1. There was no signiﬁcant
diﬀerence between these two groups.
The VAS scores of two groups at diﬀerent time points
were displayed in Table 2. There was no signiﬁcant diﬀerence
between the VAS scores of these two groups before therapy.
In both groups, the average pain scores at posttherapy time
point were signiﬁcantly lower than that at pretherapy; there
were signiﬁcant diﬀerences between these two groups at
posttherapy (Tables 2 and 3).
There was no signiﬁcant diﬀerence in the eﬀect at the
point of 6 months after therapy that nearly reached the same
levels at pretherapy (P>0.05). There was no eﬀect of age
or gender on treatment eﬀect. There was not enough data to
analyze the eﬀect of disease type. No thermal injury or other
complications were observed in the study.
5. Discussion
The major ﬁnding of this study is that the LPNIR as an add-
on method to NB or LB has synergistic eﬀect on relieving
pain of shoulder periarthritis, myofascial pain syndrome, or
lateral epicondylitis in the acute phase.
Previous data show that LPNIR is safe and eﬀective in
relievingchronicpainandotherconditions.Basfordetal.[4]
investigated the safety and eﬀects of LPNIR in a two-phase
study, in which they ﬁrst established its safety in 6 adults
with normal neurological examination by transcutaneous
irradiationwithLPNIR;thentheydemonstratedinadouble-
blind study consisted of 12 subjects with upper extremity
complex regional pain syndrome I, showing that irradiation
can induce more than 50 percent pain reduction. Demura
et al. [2] found that LPNIR can signiﬁcantly increase the
ranges of the shoulders and ankle motion in the treated
group when compared with the placebo. Yokoyama and Oku
[5] ﬁrst treated 4 patients with rheumatoid arthritis-aﬀected
temporomandibular joint pain and who were refractory to
antirheumatic agents, obtained satisﬁed pain relief with only
four treatments. They later observed the same eﬀects in
20 patients who were suﬀering from temporomandibular
pain due to nonrheumatic arthritis and who were without
attenuation after conservative treatments [1]. Mibu et al.
[6] treated 35 patients and found that LPNIR is a safe and
eﬀective measure for intractable anorectal pain.
In line with these ﬁndings, we found that LPNIR had
synergic eﬀect with NB or LB in treating chronic pain from
shoulder periarthritis, back myofascial pain syndrome, or
lateral epicondylitis.
This is within expectation in view of the following
ﬁndings: ﬁrst, LPNIR treatment near the stellate ganglion
results in the increase of blood ﬂow velocity similar to that
causedbystellateganglionblock[7];second,double-blinded
study showed that LPNIR induces warmth in the treated
areas [4].
Local heating has long been proved to have pain-
relieving eﬀects and can increase elasticity of connective
tissue and joint range [8, 9]. The mechanisms involved in
it may include increasing local blood ﬂow and enhancing
mild inﬂammatory reaction mediated through the release
of histamine and prostaglandins; promoting vasodilatation;
changing enzyme activity and metabolic rate; increasing
pain threshold through a direct action of heat upon free
nerve endings or nerve trunk that supply the aﬀected area
by various mechanisms, including impacting on neuronal
membrane potential [8, 10]. Laser irradiation, which also
causes warm sensation, has indeed been proved to decrease
sensory nerve conduction velocity and compromise the
response of dorsal horn neurons to formalin [11, 12].
The infrared light is a form of electromagnetic radiation
withwavelengthslongerthanvisiblelight,whichisgenerated
by objects that produce heat, such as human beings.
According to its wavelength, infrared light is subdivided into:
near-, mid-, and far-infrared light. Polarization can give it a
predictable fashion with respect to the propagation direction
in which way energy is focused.
The infrared rays with wavelength of 600–1600nm in
LPNIR are capable of reaching the deeper tissues, not readily
reﬂected, dispersed, or absorbed at the surface of the body
[13], and the energy light is partially converted to thermal
energy and produces warming sensation.
I n d e e d ,K a s h i m ae ta l .[ 3] observed changes in sensory
and pain perception thresholds in the trigeminal region, and
Muneshige et al. [14] observed antinociceptive eﬀects in vivo
in rats after the treatment of LPNIR.
It seems that in our settings the eﬀects of the treatment
can last no longer than 6 months.
In accordance with the previous observations, we did not
observe any side eﬀects related to the treatment of LPNIR in
any of our patients.4 The Scientiﬁc World Journal
Thelimitationofthisstudyisthatthenumberofpatients
of each type of diseases is too small to allow us to draw a
conclusion on the eﬀect of disease type. Further larger trial is
needed to clarify this.
6. Conclusions
Our study shows that LPNIR is an eﬀective and safe modality
totreatvariouschronicpains,whichhassynergiceﬀectswith
NB or LB.
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